SymBio Pharmaceuticals Statistics
Total Valuation
SYMQY has a market cap or net worth of 33.94 million. The enterprise value is 28.03 million.
| Market Cap | 33.94M |
| Enterprise Value | 28.03M |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +11.34% |
| Shares Change (QoQ) | +11.30% |
| Owned by Insiders (%) | 4.26% |
| Owned by Institutions (%) | 0.88% |
| Float | 56.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.07 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.92 |
| EV / Sales | 3.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 1.56.
| Current Ratio | 2.96 |
| Quick Ratio | 2.44 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.71 |
Financial Efficiency
Return on equity (ROE) is -174.65% and return on invested capital (ROIC) is -987.08%.
| Return on Equity (ROE) | -174.65% |
| Return on Assets (ROA) | -62.82% |
| Return on Invested Capital (ROIC) | -987.08% |
| Return on Capital Employed (ROCE) | -172.32% |
| Weighted Average Cost of Capital (WACC) | 5.15% |
| Revenue Per Employee | 77,224 |
| Profits Per Employee | -282,063 |
| Employee Count | 108 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, SYMQY has paid 175,868 in taxes.
| Income Tax | 175,868 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.37% in the last 52 weeks. The beta is 0.11, so SYMQY's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -55.37% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 16.41 |
| Average Volume (20 Days) | 2,461 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYMQY had revenue of 8.34 million and -30.46 million in losses. Loss per share was -0.61.
| Revenue | 8.34M |
| Gross Profit | 6.04M |
| Operating Income | -28.32M |
| Pretax Income | -30.29M |
| Net Income | -30.46M |
| EBITDA | n/a |
| EBIT | -28.32M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 18.39 million in cash and 12.64 million in debt, with a net cash position of 5.75 million.
| Cash & Cash Equivalents | 18.39M |
| Total Debt | 12.64M |
| Net Cash | 5.75M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.11M |
| Book Value Per Share | 0.14 |
| Working Capital | 16.16M |
Cash Flow
| Operating Cash Flow | -29.18M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 72.45% |
| Operating Margin | -339.59% |
| Pretax Margin | -363.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SYMQY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.34% |
| Shareholder Yield | -11.34% |
| Earnings Yield | -89.74% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SYMQY has an Altman Z-Score of -14.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.52 |
| Piotroski F-Score | 1 |